Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer
Titel:
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer
Auteur:
Rasul, Sazan Hartenbach, Markus Wollenweber, Tim Kretschmer-Chott, Elisabeth Grubmüller, Bernhard Kramer, Gero Shariat, Shahrokh Wadsak, Wolfgang Mitterhauser, Markus Pichler, Verena Vraka, Chrysoula Hacker, Marcus Haug, Alexander R.
Verschenen in:
European journal of nuclear medicine and molecular imaging